Sanofi | Omløpsmidler

Current Assets Endring Dato
AbbVie USD 38.87B 5.65B 2024-03
Amgen USD 28.03B 2.3B 2024-03
AstraZeneca USD 25.59B 540M 2024-03
Bristol-Myers Squibb USD 28.67B 1.04B 2024-03
Canopy Growth CAD 371.18M 26.1M 2024-03
Catalent USD 2.52B 47M 2024-03
Corcept Therapeutics USD 503.37M 44.73M 2024-03
Drreddys Laboratories INR 238.48B 20.78B 2023-12
Eli Lilly USD 25.19B 2.18B 2024-03
Galapagos EUR 3.79B 75.12M 2024-03
Genmab DKK 34.37B 1.23B 2024-03
GlaxoSmithKline GBP 17.21B 1.44B 2024-03
Glaxosmithkline GBP 17.21B 1.44B 2024-03
J&J USD 57B 3.3B 2024-03
Merck USD 31.44B 509M 2024-03
Novartis USD 26.45B 4.03B 2024-03
Novartis USD 26.45B 4.03B 2024-03
Pacira USD 543.11M 33.12M 2024-03
Perrigo USD 2.81B 26.5M 2024-03
Pfizer USD 42.42B 31.6B 2024-03
Prestige Brands USD 375.04M 18.74M 2024-03
Roche Holding CHF 33.45B 2.47B 2023-12
Supernus Pharmaceuticals USD 544.32M 51.21M 2024-03
UCB EUR 3.44B 443M 2023-12
Zoetis USD 6.36B 16M 2024-03



Sanofi Omløpsmidler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.